Abstract:OBJECTIVE: In this randomized controlled trial, we compared the effect of celecoxib and acetaminophen on pain and magnetic resonance imaging (MRI) scores in patients with chronic nonspecific low back pain.METHODS: A total of 50 patients with chronic nonspecific low back pain were blindly randomized into 2 groups treated with celecoxib (200 mg twice daily) or acetaminophen (500 mg twice daily). Outcome measures included total back pain, nocturnal back pain, Oswestry Disability Index (ODI) scores, the Short Form 36 health survey to assess physical and mental status, and patient global assessment. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index, and Bath Ankylosing Spondylitis Metrology Index scores were also assessed before and after the therapy. The Spondyloarthritis Research Consortium of Canada scoring method was used to evaluate spinal MRI changes.RESULTS: Celecoxib showed a superior effect on total back pain, ODI, BASDAI, nocturnal back pain, and patient global assessment, compared to acetaminophen (P < 0.05). The number of patients with a significant change in back pain scales was higher in the celecoxib arm (ODI 34.8% versus 4.5%, nocturnal back pain 41.7% versus 9.1%, total back pain 33.3% versus 9.1%, and BASDAI 30.4% versus 9.1%; P < 0.01 for all). The responsiveness to celecoxib, calculated by Guyatt's Responsiveness Index, was 1.62, 1.28, 1.27, and 0.58 for the ODI, total back pain, BASDAI, and nocturnal back pain, respectively. The MRI scores for sacroiliac joints and spine showed no significant change with either treatment when compared with baseline values (P > 0.05).CONCLUSION: There was superior efficacy of celecoxib compared with acetaminophen in chronic nonspecific low back pain. Inflammatory lesions of sacroiliac joints and spine are commonly seen in nonspecific low back pain, but these lesions did not change with either celecoxib or acetaminophen treatments and were not associated with clinical response to either agent.

[Clinical Evaluation of Celecoxib in Treating Type IIIA Chronic Prostatitis].

Prostatic Calculi Influence the Antimicrobial Efficacy in Men with Chronic Bacterial Prostatitis

Fluoxetine Ameliorates Symptoms of Refractory Chronic Prostatitis/chronic Pelvic Pain Syndrome.

The study of selective COX-2 inhibitor in the treatment of chronic pelvic pain syndrome

Study of cyclooxygenase-2 inhibitor combined with Qianliehuichun capsule on chronic pelvic pain syndrome

Diversity and molecular characterization of novel hemoplasmas infecting wild rodents from different Brazilian biomes.

The Efficacy and Safety of ProstantTM in the Treatment of Chronic Prostatitis: a Multi-Center,randomized,double-blind,placebo-controlled Clinical Trial

A Clinical Survey of Combined Use of Different Drugs in the Treatment of Chronic Prostatitis(report of 153 Cases)

The Efficacy and Safety of ProstantTM in the Treatment of Chronic Prostatitis:A Multi Center, Randomized, Double Blinded, Placebo Controlled Trial

[Transperineal Ultrasonic Therapy for Chronic Prostatitis].

Efficacy And Safety Of Ningmitai Capsule In Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Re-evalutation of diagnosis and treatment of chronic prostatitis

Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-Analysis of 11 Randomized Clinical Trials

[A Multi-Center Clinical Trial of Qianlieantong Tablets for Chronic Prostatitis].

Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled Trial

[A Clinical Study of Prostat Combined with an Antibiotic for Chronic Nonbacterial Prostatitis].

Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Sham Acupuncture Controlled Trial

Pumpkin seeds, Centella asiatica, Boswellia, Helichrysum, acetate vitamin E, Melaleuca alternifolia and hyaluronic acid phytocomplex monotherapy effects in patients with chronic pelvic pain syndrome.

Thermoluminescence emission spectra for the LiF:Mg,Cu,Na,Si thermoluminescent materials with various concentrations of the dopants (3-D measurement).

The Study of Terazosin in the Treatment of Chronic Prostatitis III_B

Efficacy and Safety of a Natural Supplement Containing Serenoa Repens, Solanum Lycopersicum, Lycopene, and Bromelain in Reducing Symptoms of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Cohort Study in 250 Patients